Eldridge Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Eldridge Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$348K	Sell	708 -44	-6%	-$23.9K	0.08%	127
2025 Q4	$436K	Buy	752 +44	+6%	+$24.9K	0.1%	121
2025 Q3	$343K	Hold	708	–	–	0.08%	132
2025 Q2	$287K	Hold	708	–	–	0.06%	138
2025 Q1	$352K	Hold	708	–	–	0.08%	129
2024 Q4	$368K	Hold	708	–	–	0.09%	120
2024 Q3	$438K	Hold	708	–	–	0.1%	115
2024 Q2	$392K	Buy	708 +3	+0.4%	+$1.72K	0.1%	111
2024 Q1	$410K	Buy	705 +7	+1%	+$3.93K	0.11%	111
2023 Q4	$371K	Hold	698	–	–	0.1%	112
2023 Q3	$353K	Sell	698 -80	-10%	-$42.6K	0.12%	106
2023 Q2	$406K	Hold	778	–	–	0.13%	98
2023 Q1	$448K	Hold	778	–	–	0.16%	86
2022 Q4	$428K	Buy	778 +50	+7%	+$26.5K	0.15%	88
2022 Q3	$369K	Hold	728	–	–	0.14%	95
2022 Q2	$396K	Hold	728	–	–	0.15%	85
2022 Q1	$430K	Hold	728	–	–	0.15%	85
2021 Q4	$486K	Hold	728	–	–	0.16%	81
2021 Q3	$416K	Hold	728	–	–	0.15%	80
2021 Q2	$367K	Hold	728	–	–	0.13%	85
2021 Q1	$332K	Hold	728	–	–	0.13%	86
2020 Q4	$339K	Hold	728	–	–	0.14%	78
2020 Q3	$321K	Sell	728 -6	-0.8%	-$2.48K	0.15%	72
2020 Q2	$266K	Buy	734 +6	+0.8%	+$2.01K	0.13%	80
2020 Q1	$206K	Hold	728	–	–	0.12%	85
2019 Q4	$237K	Hold	728	–	–	0.12%	85
2019 Q3	$212K	Hold	728	–	–	0.11%	91
2019 Q2	$214K	Buy	+728	New	+$201K	0.11%	81

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eldridge Investment Advisors's TMO Position: Q1 2026 in Review

Eldridge Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 5.9% in Q1 2026, selling an estimated $23.9K and leaving 708 shares worth $348K. The position accounts for 0.08% of the portfolio, ranked #127.

Eldridge Investment Advisors first reported a position in TMO in Q2 2019 and has held it in 28 quarters since. The position peaked at $486K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Eldridge Investment Advisors held 708 shares of Thermo Fisher Scientific worth $348K as of Q1 2026.
Eldridge Investment Advisors sold 44 Thermo Fisher Scientific shares in Q1 2026, an estimated $23.9K.
Thermo Fisher Scientific made up 0.08% of Eldridge Investment Advisors's portfolio in Q1 2026, its #127 holding.
Eldridge Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 28 quarters since.
Eldridge Investment Advisors's Thermo Fisher Scientific position peaked at $486K in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Eldridge Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.